DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Di Nisio M, Ageno W, Rutjes AW, Pap AF, Büller HR.
Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or with heparin and vitamin K antagonists.
Thromb Haemost 2016;
115 (02) 424-432
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.